Kobayashi Pharmaceutical Company Limited Announces Earnings Results for the Year Ended March 31, 2016; Provides Earnings Guidance for the Year Ending December 31, 2016
June 07, 2016 at 12:26 am
Share
Kobayashi Pharmaceutical Company Limited announced earnings results for the year ended March 31, 2016. For the year, the company reported net income attributable to owners of the parent company of JPY 13.47 billion, or JPY 331.11 per share, compared to JPY 12.45 billion, or JPY 305.46 per share, for the year ended March 31, 2015. Net sales were JPY 137.21 billion compared to JPY 128.34 billion for the year ended March 31, 2015. Operating income was JPY 18.26 billion compared to JPY 17.92 billion for the year ended March 31, 2015.
For the year ending December 31, 2016, the company expects net income attributable to owners of the parent company to be JPY 13.5 billion, or JPY 168.05 per share. For the year ending December 31, 2016, the company expects net sales to be JPY 117.3 billion.
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
Kobayashi Pharmaceutical Company Limited Announces Earnings Results for the Year Ended March 31, 2016; Provides Earnings Guidance for the Year Ending December 31, 2016